In vitro activities of telithromycin against Staphylococcus aureus biofilms compared with azithromycin, clindamycin, vancomycin and daptomycin

被引:15
|
作者
Zheng, Jin-xin [1 ,2 ,3 ,4 ,5 ,6 ]
Tu, Hao-peng [4 ,5 ,6 ]
Sun, Xiang [4 ,5 ,6 ]
Xu, Guang-jian [4 ,5 ,6 ]
Chen, Jun-wen [4 ,5 ,6 ]
Deng, Qi-wen [4 ,5 ,6 ]
Yu, Zhi-jian [4 ,5 ,6 ]
Qu, Di [1 ,2 ,3 ]
机构
[1] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Minist Educ,Key Lab Med Mol Virol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Minist Hlth,Key Lab Med Mol Virol, Shanghai 200032, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China
[4] Shenzhen Univ, Hlth Sci Ctr, Shenzhen Nanshan Peoples Hosp, Dept Infect Dis, Shenzhen 518052, Peoples R China
[5] Shenzhen Univ, Hlth Sci Ctr, Shenzhen Nanshan Peoples Hosp, Key Lab Endogenous Infect, Shenzhen 518052, Peoples R China
[6] Shenzhen Univ, Hlth Sci Ctr, Affiliated Hosp 6, Shenzhen 518052, Peoples R China
关键词
Staphylococcus aureus; telithromycin; biofilm; adherent cells; subinhibitory concentrations; HIGH-DOSE DAPTOMYCIN; MODEL;
D O I
10.1099/jmm.0.001122
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction. Staphylococcus aureus biofilms are difficult to treat and the effect of telithromycin treatment is still unclear. Aim. This study aimed to explore the effect of telithromycin against Staphylococcus aureus biofilms compared with azithromycin, clindamycin, vancomycin and daptomycin. Methodology. Eight methicillin-susceptible and eight methicillin-resistant S. aureus isolates (MSSA and MRSA, respectively) were used for this study. Biofilm biomasses were detected by crystal violet staining and the adherent cells in the established biofilms were quantified by determination of colony-forming units (c.f.u.). The RNA levels of biofilm formation-related genes were determined by RT-qPCR. Results. Telithromycin [8x minimum inhibitory concentration (MIC)] eradicated more established biofilms than azithromycin or clindamycin in the four MSSA isolates, and eliminated the established biofilms of six MRSA isolates more effectively than vancomycin or daptomycin. Telithromycin (8x MIC) killed more adherent cells in the established biofilms than azithromycin or clindamycin in the six MSSA isolates, and killed more adherent cells than vancomycin in all eight MRSA isolates. Daptomycin also showed an excellent effect on the adherent cells of MRSA isolates, with similarresults to telithromycin. The effect of a subinhibitory concentration of telithromycin (1/4x MIC) was significantly superior to that of azithromycin or clindamycin, inhibiting the biofilm formation of six MSSA isolates and seven MRSA isolates more effectively than vancomycin or daptomycin. The RNA levels of agrA, agrC, clfA, icaA and sigB decreased when treated with telithromycin (1/4x MIC). Conclusions. Telithromycin is more effective than azithromycin, clindamycin, vancomycin, or daptomycin against S. aureus biofilms.
引用
收藏
页码:120 / 131
页数:12
相关论文
共 50 条
  • [41] Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid
    Saravolatz, Louis D.
    Pawlak, Joan M.
    Wegner, Corinne
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (09) : 2605 - 2608
  • [42] Effects of Vancomycin, Daptomycin, Fosfomycin, Tigecycline, and Ceftriaxone on Staphylococcus epidermidis Biofilms
    Hajdu, Stefan
    Lassnigg, Andrea
    Graninger, Wolfgang
    Hirschl, Alexander M.
    Presterl, Elisabeth
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2009, 27 (10) : 1361 - 1365
  • [43] Telavancin and daptomycin activity against meticillin-resistant Staphylococcus aureus strains after vancomycin-resistance selection in vitro
    Taglietti, Fabrizio
    Principe, Luigi
    Bordi, Eugenio
    D'Arezzo, Silvia
    Di Bella, Stefano
    Falasca, Laura
    Piacentini, Mauro
    Stefani, Stefania
    Petrosillo, Nicola
    JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 62 : 1101 - 1102
  • [44] Activity of daptomycin, ciprofloxacin, clindamycin and cotrimoxazole against coagulase-negative Staphylococcus strains with diminished susceptibility to vancomycin
    Fajardo Olivares, Miguel
    Hidalgo Orozco, Rocio
    Rodriguez Gutierrez, Saray
    Garduno Eseverri, Eugenio
    Rodriguez Vidigal, Francisco Felix
    Robles Marcos, Manuel
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2010, 23 (02) : 81 - 86
  • [45] Short-course gentamicin in combination with Daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations
    Tsuji, BT
    Rybak, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) : 2735 - 2745
  • [46] Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro
    Jorgensen, Nis Pedersen
    Skovdal, Sandra M.
    Meyer, Rikke L.
    Dagnaes-Hansen, Frederik
    Fuursted, Kurt
    Petersen, Eskild
    PATHOGENS AND DISEASE, 2016, 74 (04): : ftw019
  • [47] Susceptibility of Staphylococcus aureus Biofilms to Vancomycin, Gentamicin and Rifampin
    Kotulova, D.
    Slobodnikova, L.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2010, 59 (02): : 80 - 87
  • [48] Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin
    Matic, V
    Kosowska, K
    Bozdogan, B
    Kelly, LM
    Smith, K
    Ednie, LM
    Lin, GR
    Credito, KL
    Clark, CL
    McGhee, P
    Pankuch, GA
    Jacobs, MR
    Appelbaum, PC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) : 4103 - 4112
  • [49] The mode of action of daptomycin against Staphylococcus aureus
    Hobbs, J.
    Miller, K.
    Read, N.
    Chopra, I.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S53 - S53
  • [50] In Vitro Activities Against Clinical Isolates of Staphylococcus aureus
    Koteli, A.
    Kakoulidou, A.
    Tsingene, S.
    Andronoglou, M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E272 - E272